Merck & Co., Inc., Rahway, NJ, USA is known as MSD outside of the United States and Canada.

Merck & Co., Inc., Rahway, NJ, USA is known as MSD outside of the United States and Canada.

The merger to create Merck Sharp & Dohme (MSD) [(headquartered in Rahway, New Jersey, U.S.)] brought together our extensive chemical research and manufacturing facilities with Sharp & Dohme's pharmaceutical development, marketing expertise and international presence.

Dec 31, 2023 · At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world.

MSD's U.S. headquarters, worldwide office, adverse event, investors, media, supplies and animal health contact information.

MSD Animal Health is our company's global animal health business dedicated to preserving and improving the health, well-being and performance of both livestock and companion animals and the people who care for them.

RAHWAY, N.J., Oct. 1, 2024 – MSD (tradename of Merck & Co., Inc., Rahway, N.J., USA) (NYSE: MRK) today announced the completion of the acquisition of CN201 from Curon Biopharmaceutical (Curon), a novel investigational clinical-stage bispecific antibody for the treatment of B-cell associated diseases.

MSD’s business development and licensing team explain how they identify new opportunities to strengthen our robust R&D pipeline

RAHWAY, N.J., December 18, 2024 – MSD (tradename of Merck & Co., Inc., Rahway, N.J., USA) and Hansoh Pharma, a Chinese biopharmaceutical company, today announced that they have entered into an exclusive global license agreement for HS-10535, an investigational preclinical oral small molecule GLP-1 receptor agonist.

At MSD, we follow the science. Learn about MSD's research and products by getting to know the science, strategy and brains behind the innovations.